153 related articles for article (PubMed ID: 30081046)
1. P75 Involved in the Ubiquitination of α-synuclein in Rotenone-based Parkinson's Disease Models.
Chen Y; Hou Y; Yang J; Du R; Chen C; Chen F; Wang H; Ge R; Chen J
Neuroscience; 2018 Sep; 388():367-373. PubMed ID: 30081046
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death.
Lee JT; Wheeler TC; Li L; Chin LS
Hum Mol Genet; 2008 Mar; 17(6):906-17. PubMed ID: 18065497
[TBL] [Abstract][Full Text] [Related]
3. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration.
Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M
Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of bcl-2 enhanced rotenone-induced α-synuclein aggregation associated with autophagic pathways.
Chen Y; Zhang N; Ji D; Hou Y; Chen C; Fu Y; Ge R; Zheng Q; Chen J; Wang H
Neuroreport; 2018 Sep; 29(14):1201-1208. PubMed ID: 30059366
[TBL] [Abstract][Full Text] [Related]
5. Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease.
Davies SE; Hallett PJ; Moens T; Smith G; Mangano E; Kim HT; Goldberg AL; Liu JL; Isacson O; Tofaris GK
Neurobiol Dis; 2014 Apr; 64(100):79-87. PubMed ID: 24388974
[TBL] [Abstract][Full Text] [Related]
6. Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells.
Rott R; Szargel R; Haskin J; Shani V; Shainskaya A; Manov I; Liani E; Avraham E; Engelender S
J Biol Chem; 2008 Feb; 283(6):3316-3328. PubMed ID: 18070888
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells.
Chen Y; Lian YJ; Ma YQ; Wu CJ; Zheng YK; Xie NC
Neurotoxicology; 2018 Sep; 68():212-221. PubMed ID: 29217406
[TBL] [Abstract][Full Text] [Related]
8. Synphilin-1A inhibits seven in absentia homolog (SIAH) and modulates alpha-synuclein monoubiquitylation and inclusion formation.
Szargel R; Rott R; Eyal A; Haskin J; Shani V; Balan L; Wolosker H; Engelender S
J Biol Chem; 2009 Apr; 284(17):11706-16. PubMed ID: 19224863
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
Liani E; Eyal A; Avraham E; Shemer R; Szargel R; Berg D; Bornemann A; Riess O; Ross CA; Rott R; Engelender S
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5500-5. PubMed ID: 15064394
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease.
Engelender S
Autophagy; 2008 Apr; 4(3):372-4. PubMed ID: 18216494
[TBL] [Abstract][Full Text] [Related]
12. Treadmill Exercise Attenuates α-Synuclein Levels by Promoting Mitochondrial Function and Autophagy Possibly via SIRT1 in the Chronic MPTP/P-Induced Mouse Model of Parkinson's Disease.
Koo JH; Cho JY
Neurotox Res; 2017 Oct; 32(3):473-486. PubMed ID: 28656548
[TBL] [Abstract][Full Text] [Related]
13. Silencing of SIAH1 in SH-SY5Y affects α-synuclein degradation pathway.
Xu J; Zhang XZ; Zhang YJ; Li XM; Cai ZL; Li XM
Int J Clin Exp Pathol; 2015; 8(10):12885-92. PubMed ID: 26722480
[TBL] [Abstract][Full Text] [Related]
14. Hydroxysafflor yellow A promotes α-synuclein clearance via regulating autophagy in rotenone-induced Parkinson's disease mice.
Han B; Wang L; Fu F; Wang Z; Zhang L; Qi GJ; Wang T
Folia Neuropathol; 2018; 56(2):133-140. PubMed ID: 30509033
[TBL] [Abstract][Full Text] [Related]
15. Flavin-containing monooxygenase, a new clue of pathological proteins in the rotenone model of parkinsonism.
Li B; Yuan Y; Zhang W; He W; Hu J; Chen N
Neurosci Lett; 2014 Apr; 566():11-6. PubMed ID: 24440618
[TBL] [Abstract][Full Text] [Related]
16. Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease.
Sala G; Marinig D; Riva C; Arosio A; Stefanoni G; Brighina L; Formenti M; Alberghina L; Colangelo AM; Ferrarese C
Neurotoxicology; 2016 May; 54():161-169. PubMed ID: 27133439
[TBL] [Abstract][Full Text] [Related]
17. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
[TBL] [Abstract][Full Text] [Related]
18. Roflupram protects against rotenone-induced neurotoxicity and facilitates α-synuclein degradation in Parkinson's disease models.
Dong WL; Zhong JH; Chen YQ; Xie JF; Qin YY; Xu JP; Cai NB; Li MF; Liu L; Wang HT
Acta Pharmacol Sin; 2021 Dec; 42(12):1991-2003. PubMed ID: 34531546
[TBL] [Abstract][Full Text] [Related]
19. An 11-mer Amyloid Beta Peptide Fragment Provokes Chemical Mutations and Parkinsonian Biomarker Aggregation in Dopaminergic Cells: A Novel Road Map for "Transfected" Parkinson's.
Kabiraj P; Marin JE; Varela-Ramirez A; Narayan M
ACS Chem Neurosci; 2016 Nov; 7(11):1519-1530. PubMed ID: 27635664
[TBL] [Abstract][Full Text] [Related]
20. Neuronal Bmi-1 is critical for melatonin induced ubiquitination and proteasomal degradation of α-synuclein in experimental Parkinson's disease models.
Srivastava AK; Choudhury SR; Karmakar S
Neuropharmacology; 2021 Aug; 194():108372. PubMed ID: 33157086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
